Time: 2023-01-16
Views: 365
TJP Labs Inc. announced that the U.S. Food and Drug Administration has accepted its Premarket Tobacco Product Application (PMTA) submission for its proposed brand, L!X Modern Oral Nicotine Pouches.
Marketed under the name L!X Nicotine Pouches by its subsidiary L!X Innovations Inc., the brand's application is now in the next step of the PMTA review process.
TJP Labs CEO David Richmond-Peck said in his remarks:
"The PMTA process is a competitive and rigorous science-based review, and acceptance of this application is an important milestone in our global harm reduction strategy. We look forward to working with the FDA as we know our products have the potential to reduce harm from nicotine in adults consumer."
"TJP Labs strategically focused on the new modern oral market several years ago. As a result, our world-class manufacturing facilities, robust quality management system and flavor-rich formulations allow us to establish ourselves in categories beyond modern oral and nicotine A solid foundation. I congratulate our quality, manufacturing and regulatory teams for their continued success."
"As we embarked on our global harm reduction journey, we knew we had to create a premium product that respected the Swedish snus tradition and combined the advantages of a modern pouch format. Our various focus groups and consumer tests proved that L!X Nicotine pouches are one of the best choices in the global market for their long-lasting flavor and smooth taste. We believe our brand will soon become the brand of choice for consumers around the world.”
TJP Labs Inc. is a North American focused full-service contract manufacturer of next-generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceuticals.